ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677921; 2) Community: the network communities that were significantly associated with the response to NSC 677921; 3) Molecule: the relationships between components within communities and NSC 677921; 4) MDR: the compounds that were significantly associated with the NSC 677921.

NSC Compound Enrichment Correlation
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0385613993886001 -0.11835105
NSC 39215 Null 0.0385613993886001 0.24897754
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0385613993886001 0.15964448
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.0385613993886001 -0.22954447
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0385613993886001 0.47471342
NSC 626162 Discorhabdin C . TFA 0.0385613993886001 0.36733515
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0385613993886001 0.36190636
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0385613993886001 -0.24142032
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0385613993886001 0.19764744
NSC 638624 Null 0.0385613993886001 0.12709777
Total:45  Current:28    [First] [Prev] [Next] [Last]